← Back to Search

Electrolyte Supplement

Lidocaine-ineffective ADHD: Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

Phase 1 & 2
Waitlist Available
Led By Michael M Segal, MD PhD
Research Sponsored by AlkaliDx, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and ~1-2 hours later, 1 hour after intervention
Awards & highlights

Summary

This trial is testing if a single dose of potassium can help reduce symptoms in people with ADHD who haven't been treated or whose current treatments aren't working well. Potassium is a mineral that helps with nerve function and muscle control. The study will measure changes in ADHD symptoms after taking potassium.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and ~1 hour after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and ~1 hour after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Prevalence of lidocaine ineffectiveness in those with ADHD
Secondary study objectives
Change in ADHD-RS questionnaires
Change in Clinical Global Impression Physician Completed Questionnaire
Change in scores using Quotient ADHD System
+2 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Lidocaine-ineffective ADHD: InterventionActive Control1 Intervention
Single-dose potassium gluconate oral capsule intervention for ADHD subjects for whom lidocaine is ineffective
Group II: Lidocaine-effective ADHD: InterventionActive Control1 Intervention
Single-dose potassium gluconate oral capsule intervention for ADHD subjects for whom lidocaine is effective
Group III: Lidocaine-effective ADHD: PlaceboPlacebo Group1 Intervention
Single-dose placebo oral capsule intervention for ADHD subjects for whom lidocaine is effective
Group IV: Lidocaine-ineffective ADHD: placeboPlacebo Group1 Intervention
Single-dose placebo oral capsule intervention for ADHD subjects for whom lidocaine is ineffective

Find a Location

Who is running the clinical trial?

AlkaliDx, Inc.Lead Sponsor
Michael M Segal, MD PhDPrincipal InvestigatorPhenoSolve, LLC
2 Previous Clinical Trials
45 Total Patients Enrolled
Mark Mintz, MDPrincipal InvestigatorCNNH & CRCNJ
~14 spots leftby Sep 2025